 While this type of expression has been successfully carried out in yeast, the results in mammals have been conflicting.Gensight Biologics are currently pursuing a clinical program of expressing the ND4 gene in the nucleus to prevent retinal disease.The SENS Research Foundation recently reported success in expressing the ATP6 gene allotopically in vitro.